Pre-exposure prophylaxis with tixagevimab and cilgavimab (Evusheld) for COVID-19 among 1112 severely immunocompromised patients

Clinical Microbiology and Infection
August 1, 2022
Cited by 109


Related Papers

No related papers found

Powered by citation graph analysis